This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PHILIP C. JOHNSON, MD; RICHARD M. LEWIS, MD; CHARLES T. VAN BUREN, MD; BARRY D. KAHAN, PHD, MD
Houston

Arch Surg. 1988;123(7):912-913.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—We read with interest the study by Franson et al¹ that reported five cases of Pneumocystis carinii pneumonia (PCP) among 11 renal transplant recipients receiving cyclosporine-prednisone immunosuppression. They concluded that cyclosporine immunosuppression may be related to the development of PCP. We would like to report our experience among 227 cyclosporine-treated renal transplant recipients who received cyclosporine-prednisone immunosuppression, 55 of whom developed diffuse interstitial infiltrates and underwent bronchial alveolar lavage and bronchial brushings as part of a standard protocol to diagnose pulmonary infections in transplant recipients.

Patients and Methods.—We observed nine (4%) of 227 cyclosporine-treated patients who had PCP from February 1985, to May 1987, before we routinely instituted prophylactic trimethoprim-sulfamethoxazole prophylaxis during the first six months after transplantation. This incidence is similar to that in a previous report from our institution.²Pneumocystis carinii pneumonia occurred an average of 97 days (range, 53 to 133 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?